Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 15.4.2024B.Braun Melsungen AG (BME)4143CIbuprofen B. Braun 400 mg (sol inf 10x400 mg/100 ml (fľ.LDPE))15.4.2024R
 15.4.2024Zentiva, k.s. (ZNT-1)01077OPHTHALMO-FRAMYKOIN comp. (ung oph 1x5 g (tuba Al))15.4.2024O
 15.4.2024Zentiva, k.s. (ZNT-1)02479Dithiaden (tbl 20x2 mg (blis. PVC/Al))15.4.2024O
 15.4.2024Zentiva, k.s. (ZNT-1)3073BTorvacard Novum 80 mg (tbl flm 30x80 mg (blis.OPA/Al/PVC/Al))15.4.2024O
 15.4.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)84495TRIFED EXPECTORANT (sir 1x100 ml (fľ.PVC hnedá))12.4.2024O
 12.4.2024N.V. Organon (ORG-NL)05878Montelukast Organon 10 mg (tbl flm 56x10 mg (blis.Al/Al))11.4.2024O
 12.4.2024N.V. Organon (ORG-NL)56940Lotriderm (crm der 1x15 g (tuba Al))11.4.2024O
 12.4.2024B.Braun Melsungen AG (BME)10440Gelaspan 4% (sol inf 20x500 ml (vak plast.-Ecobag))12.4.2024O
 12.4.2024Menarini International Operations Luxembourg S.A. (MNR)04073Omarit (tbl 10x20 mg (blis.PA/Al/PVC/Al))12.4.2024R
 12.4.2024Janssen - Cilag International N.V. (JNS)9959AVokanamet 50 mg/1000 mg filmom obalené tablety (tbl flm 60x50 mg/1000 mg (fľ.HDPE))12.4.2024R
 12.4.2024Berlin-Chemie AG (BCE)93259Oltar 3 mg (tbl 30x3 mg (blis.PVC/PVDC/Al))12.4.2024R
 12.4.2024Berlin-Chemie AG (BCE)93289Oltar 2 mg (tbl 30x2 mg (blis.PVC/PVDC/Al))12.4.2024R
 12.4.2024MEDOCHEMIE Ltd. (MOE)67520MEDOCIPRIN 500 mg (tbl flm 10x500 mg (blis.PVC/Al))8.4.2024O
 12.4.2024MEDOCHEMIE Ltd. (MOE)93336Mabron Retard 200 (tbl plg 30x200 mg (blis.Al/PVC))8.4.2024O
 12.4.2024MEDOCHEMIE Ltd. (MOE)9445BZEPILEN 1 g (plo ijf 10x1 g (liek.inj.skl.))8.4.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)